Read + Share
Kennedy KR, Turner JH, MacDonald WBG, Claringbold PG, et al. Long-term survival and toxicity in patients with neuroendocrine tumors treated
with (177) Lu-octreotate peptide radionuclide therapy. Cancer 2022;128:2182-2192.
PMID: 35363879
|
 |
|
